DarioHealth Corp. 8-K Filing: Key Updates as of January 2025

Based on the provided section of the financial report, here are the key pieces of information extracted:
- Entity Information:
- Company Name: DarioHealth Corp.
- CIK (Central Index Key): 0001533998
- SEC Filing Type: 8-K
- SEC Central File Number: 001-37704
- EIN (Employer Identification Number): 45-2973162
- Address: 322 W 57th St #33B, New York, NY 10019
- Phone Number: 972-4-770-6377
- Filing Date:
- Date of Report: January 7, 2025
- Stock Information:
- Type of Stock: Common Stock
- Par Value: $0.0001 per share
- Ticker Symbol: DRIO
- Exchange: NASDAQ
- Context and Measurement:
- Reporting Date Context: As of January 7, 2025
- Currency: USD (U.S. Dollars)
- Unit of Measure for Shares: Shares
- General Notes:
- This filing is a Form 8-K, which typically reports significant events that shareholders should know about.
- The report seems to be structured in XBRL (eXtensible Business Reporting Language), which is used for digital financial reporting.
Insights:
- The filing indicates that DarioHealth Corp. is actively reporting significant events as of the specified date, which is crucial for investors monitoring the company.
- The par value of the common stock is notably low, which is common for many companies and indicates a focus on share price appreciation rather than immediate dividends.
- The presence of a detailed contact address and phone number suggests transparency and accessibility for stakeholders.
Overall, this document serves as a formal communication to investors and regulatory bodies concerning DarioHealth Corp.'s status and relevant changes or events as of early January 2025.